In fact, the hepatic influx of activated CD8+ T cells and of NKT cells has been recently linked to the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis (NASH) and subsequently to hepatocellular carcinoma in experimental models and in patients (11). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.